4. Van Den Berghe G, Wilmer A, Hermans G, Et Al. (2006) Intensive Insulin Therapy in The

1

References

1. Warren BL, Eid A, Singer P, et al.; KyberSept Trial Study Group (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286:1869-1878.

2. Bernard GR, Vincent JL, Laterre PF, et al.; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709.

3. Abraham E, Reinhart K, Opal S, et al.; OPTIMIST Trial Study Group (2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003; 290:238-247.

4. Van den Berghe G, Wilmer A, Hermans G, et al. (2006) Intensive insulin therapy in the medical ICU.

N Engl J Med 354:449-61.

5. Annane D, Vignon P, Renault A, et al.; CATS Study Group (2007) Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370:676-84.

6. Russell JA, Walley KR, Singer J, et al.; VASST Investigators (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877-87.

7. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111-24.

8. Brunkhorst FM, Engel C, Bloos F, et al.; German Competence Network Sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125-39.

9. Ferrer R, Artigas A, Levy MM, et al., Edusepsis Study Group (2008) Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain.JAMA299:2294-303.

10. Finfer S, Chittock DR, Su SY, et al.; NICE-SUGAR Study Investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-97.

11. Perner A, Haase N, Guttormsen AB, et al.; 6S Trial Group; Scandinavian Critical Care Trials Group. (2012) Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 367:124-34.

12. Brunkhorst FM, Oppert M, Marx G, et al.; German Study Group Competence Network Sepsis (SepNet) (2012) Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 307:2390-9.

13. Joannes-Boyau O, Honoré PM, Perez P, et al. (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 39:1535-46.

14. Asfar P, Meziani F, Hamel JF, et al.; SEPSISPAM Investigators. High versus low blood-pressure target in patients with septic shock.N Engl J Med 370:1583-93.

15. Caironi P, Tognoni G, Masson S, et al.; ALBIOS Study Investigators (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412-21.

16. Holst LB, Haase N, Wetterslev J, et al.; TRISS Trial Group; Scandinavian Critical Care Trials Group (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371:1381-91.

17. Ranieri VM, Thompson BT, Barie PS, et al.; PROWESS-SHOCK Study Group (2012) Drotrecoginalfa (activated) in adults with septic shock. N Engl J Med 366:2055-64.

18. ProCESS Investigators: Yealy DM, Kellum JA, Huang DT, et al. (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:1683-93.

19. ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, et al. (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:1496-506.

20. Zhang Z, Ni H, Qian Z (2015) Effectiveness of treatment based on PiCCO parameters in critically ill patients with septic shock and/or acute respiratory distress syndrome: a randomized controlled trial. Intensive Care Med 41; DOI 10.1007/s00134-014-3638-4.

21. Wheeler AP, Bernard GR, Thompson BT, et al.; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network (2006) Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 354:2213-24.

22. Kesecioglu J, Beale R, Stewart TE, et al. (2009) Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 180:989-94.

23. Papazian L, Forel JM, Gacouin A, et al.; ACURASYS Study Investigators (2010) Neuromuscular blockers in early acute respiratory distress syndrome.N Engl J Med363:1107-16.

24. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Matthay MA, Brower RG, Carson S, et al. (2011) Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 184:561-8.

25. Rice TW, Wheeler AP, Thompson BT, et al.; NIH NHLBI Acute Respiratory Distress Syndrome Network of Investigators (2011) Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 306:1574-81.

26. Gao Smith F, Perkins GD, Gates S, et al.; BALTI-2 study investigators (2012) Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 379:229-35.

27. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Rice TW, Wheeler AP, Thompson BT, et al. (2012) Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 307:795-803.

28. Guérin C, Reignier J, Richard JC, et al.; PROSEVA Study Group (2013) Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368:2159-68.

29. Ferguson ND, Cook DJ, Guyatt GH, et al.; OSCILLATE Trial Investigators; Canadian Critical Care Trials Group (2013) High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 368:795-805.

30. McAuley DF1, Laffey JG, O'Kane CM, et al.; HARP-2 Investigators; Irish Critical Care Trials Group (2014) Simvastatin in the acute respiratory distress syndrome. N Engl J Med 371:1695-703.